Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $284K | $686K | $7.50K | $0.00 |
| Revenue growth | — | 141.5% | -98.9% | -100.0% |
| Operating income | -$9.45M | -$7.45M | -$11.0M | -$11.0M |
| Operating margin | -3328.7% | -1086.1% | -146468.5% | — |
| Net income | -$10.7M | -$11.3M | -$8.97M | -$11.0M |
| Net margin | -3760.7% | -1644.9% | -119566.6% | — |
| EPS (diluted) | -$12.74 | -$54.98 | -$15.70 | -$2.25 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$8.35M | -$7.36M | -$10.2M | -$11.2M |
| Capital expenditures | $33.1K | $26.5K | $8.57K | $24.2K |
| Free cash flow | -$8.38M | -$7.39M | -$10.2M | -$11.2M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $3.49M | $1.80M | $4.55M | $2.07M |
| Total assets | $7.17M | $5.12M | $7.36M | $5.03M |
| Total liabilities | $9.73M | $2.20M | $1.66M | $1.22M |
| Shareholders' equity | -$36.3M | $2.91M | $5.70M | $2.20M |
| Retained earnings | -$37.3M | -$48.6M | -$57.6M | -$68.5M |
| Shares (wtd avg diluted) | 1.06M | 230K | 571K | 4.87M |
Every figure is extracted from Azitra, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.